SRINIVAS RAVI: Open Payments
NPI 1780798868 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,222 in 208 payments from 25 companies in 2025. Trend: 2023 $3,634 · 2024 $3,800 · 2025 $4,222
Food & beverage: $4,222
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $597 |
| ABBVIE INC. | 22 | $453 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $409 |
| Ardelyx, Inc. | 21 | $376 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 27 | $344 |
| Novo Nordisk Inc | 15 | $332 |
| Otsuka America Pharmaceutical, Inc. | 11 | $305 |
| Amgen Inc. | 18 | $260 |
| Kowa Pharmaceuticals America, Inc. | 13 | $150 |
| SHIELD THERAPEUTICS INC | 2 | $147 |
Products named: JARDIANCE, IBSRELA, REXULTI, AIRSUPRA, QULIPTA, XIFAXAN, FARXIGA, ZORYVE.
Industry payments across NY — which companies pay providers there.
